NL8402046A - Preparaat voor percutane toediening, dat fysiologisch aktieve stof, hulpmiddel, oplosmiddel en een diol als moderator bevat. - Google Patents

Preparaat voor percutane toediening, dat fysiologisch aktieve stof, hulpmiddel, oplosmiddel en een diol als moderator bevat. Download PDF

Info

Publication number
NL8402046A
NL8402046A NL8402046A NL8402046A NL8402046A NL 8402046 A NL8402046 A NL 8402046A NL 8402046 A NL8402046 A NL 8402046A NL 8402046 A NL8402046 A NL 8402046A NL 8402046 A NL8402046 A NL 8402046A
Authority
NL
Netherlands
Prior art keywords
carbon atoms
alkyl group
active substance
component
methyl
Prior art date
Application number
NL8402046A
Other languages
English (en)
Dutch (nl)
Original Assignee
Nitto Electric Ind Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Ind Co filed Critical Nitto Electric Ind Co
Publication of NL8402046A publication Critical patent/NL8402046A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8402046A 1983-07-01 1984-06-28 Preparaat voor percutane toediening, dat fysiologisch aktieve stof, hulpmiddel, oplosmiddel en een diol als moderator bevat. NL8402046A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/510,133 US4590190A (en) 1983-07-01 1983-07-01 Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US51013383 1983-07-01

Publications (1)

Publication Number Publication Date
NL8402046A true NL8402046A (nl) 1985-02-01

Family

ID=24029504

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8402046A NL8402046A (nl) 1983-07-01 1984-06-28 Preparaat voor percutane toediening, dat fysiologisch aktieve stof, hulpmiddel, oplosmiddel en een diol als moderator bevat.

Country Status (10)

Country Link
US (1) US4590190A (fr)
JP (1) JPS6013721A (fr)
CA (1) CA1228027A (fr)
CH (1) CH658994A5 (fr)
DE (1) DE3424057C3 (fr)
DK (1) DK315884A (fr)
FR (1) FR2548025B1 (fr)
GB (1) GB2142237B (fr)
NL (1) NL8402046A (fr)
SE (1) SE459712B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
NL8620486A (nl) * 1985-12-04 1987-11-02 Hsieh Dean Transdermale afgifte van geneesmiddelen.
US4855132A (en) * 1986-02-25 1989-08-08 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
US4764364A (en) * 1986-02-25 1988-08-16 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
CH679119A5 (fr) * 1988-05-13 1991-12-31 Sandoz Ag
JPH02104531A (ja) * 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
US5246949A (en) * 1989-12-06 1993-09-21 Sansho Co., Ltd. Preparation for endermism containing dopamine derivatives
JPH03236317A (ja) * 1989-12-06 1991-10-22 Sansei Seiyaku Kk ドパミン誘導体含有経皮用製剤
JPH06510290A (ja) * 1991-08-27 1994-11-17 シグナス，インコーポレイテッド プラゾシンを投与するための経皮処方物
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
AU6410494A (en) * 1993-03-17 1994-10-11 Alza Corporation Device for the transdermal administration of alprazolam
CA2165802A1 (fr) * 1993-09-29 1995-04-06 Eun Soo Lee Renforcateur de permeation de l'oxybutine a base de monoglyceride/lactate
ATE228834T1 (de) * 1994-09-30 2002-12-15 Oreal Verwendung von einem agonisten eines mit einem chloridkanal assozierten rezeptors zur behandlung von hautfalten
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
DE19725615A1 (de) * 1997-06-17 1998-12-24 Permamed Ag Zur topischen Applikation bestimmte Diclofenac-Lösung
US6491575B2 (en) * 1997-07-03 2002-12-10 Andreas Sarantitis Tool for the removal of paint-like materials from work surfaces
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
ATE377048T1 (de) * 2000-09-06 2007-11-15 Ap Pharma Inc Abbaubare polyacetal-polymere
US20030152630A1 (en) * 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US6828277B2 (en) * 2003-03-24 2004-12-07 E. I. Du Pont De Nemours And Company Production of N-aryl-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds
US6818593B2 (en) * 2003-03-24 2004-11-16 E. I. Du Pont De Nemours And Company Production of 5-Methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds
US6828278B2 (en) * 2003-03-24 2004-12-07 E.I. Du Pont De Nemours And Company Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with arly amines
US6855731B2 (en) * 2003-03-24 2005-02-15 E. I. Du Pont De Nemours And Company Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with nitro compounds
US6900337B2 (en) * 2003-03-24 2005-05-31 E. I. Du Pont De Nemours And Company Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid
US20040192938A1 (en) * 2003-03-24 2004-09-30 Manzer Leo Ernest Production of 5-mehyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive of levulinic acid esters with aryl and alkyl amines
US20050158329A1 (en) * 2004-01-21 2005-07-21 Ghosh Swapan K. Novel phytol derived immunoadjuvants and their use in vaccine formulations
WO2007015441A1 (fr) * 2005-08-01 2007-02-08 Hisamitsu Pharmaceutical Co., Inc. Adjuvant ou préparation pharmaceutique pour administration transdermique ou transmucosale
JP2012507511A (ja) * 2008-10-31 2012-03-29 モバーグ ダーマ アーベー 少なくとも２種の透過増強剤を組み合わせて含む局所用組成物
WO2015064710A1 (fr) 2013-10-31 2015-05-07 久光製薬株式会社 Composition adjuvante, préparation adjuvante la contenant et kit

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227617B (de) * 1961-07-20 1966-10-27 Dr Med Friedrich Meyer Penetrationsvermittler
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
SE7506731L (sv) * 1974-07-01 1976-01-02 Merck & Co Inc Komposition for behandling av akne.
DE2528516A1 (de) * 1974-07-05 1976-01-22 Sandoz Ag Neue galenische zubereitung
GB1504302A (en) * 1974-08-23 1978-03-15 Fisons Ltd Sedative method and composition
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4017641A (en) * 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
JPS52148614A (en) * 1976-06-04 1977-12-10 Masao Yonemushi Production of additive for skin medicine
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
JPS557272A (en) * 1978-06-16 1980-01-19 Rech Pharma Sa Drug composition containing urea
CA1165240A (fr) * 1980-07-09 1984-04-10 The Procter & Gamble Company Composes pharmaceutiques a usage topique
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone

Also Published As

Publication number Publication date
SE8403487L (sv) 1985-01-02
DK315884D0 (da) 1984-06-28
SE459712B (sv) 1989-07-31
CH658994A5 (de) 1986-12-31
DE3424057C3 (de) 1992-05-07
DE3424057A1 (de) 1985-01-10
GB8415975D0 (en) 1984-07-25
FR2548025B1 (fr) 1988-04-29
DK315884A (da) 1985-01-02
US4590190A (en) 1986-05-20
JPS645579B2 (fr) 1989-01-31
JPS6013721A (ja) 1985-01-24
FR2548025A1 (fr) 1985-01-04
GB2142237B (en) 1987-09-23
DE3424057C2 (de) 1986-05-28
CA1228027A (fr) 1987-10-13
GB2142237A (en) 1985-01-16
SE8403487D0 (sv) 1984-06-29

Similar Documents

Publication Publication Date Title
NL8402046A (nl) Preparaat voor percutane toediening, dat fysiologisch aktieve stof, hulpmiddel, oplosmiddel en een diol als moderator bevat.
US4752612A (en) Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4710497A (en) Method for percutaneously administering physiologically active agents
US4605670A (en) Method for percutaneously administering metoclopramide
JPS6036423A (ja) Ｎ−（２−ヒドロキシエチル）ピロリドンを含有する浸透局所製薬組成物
KR20190003535A (ko) 전달 시스템
JPH0225429A (ja) 経皮浸透性増進方法およびそれに便利な組成物
NL8401422A (nl) Geneesmiddeldrager, deze drager bevattende farmaceutische preparaten, werkwijze voor het bereiden van een en ander alsmede methode voor percutane therapeutische behandeling met voornoemde farmaceutische preparaten.
US5128376A (en) Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
JP2570342B2 (ja) 外用液剤
NL8402045A (nl) Preparaat voor percutane toediening, dat fysiologisch aktieve stof, hulpmiddel, oplosmiddel en een diol als moderator bevat.
NZ316340A (en) 1,2,4-benzotriazine oxides aqueous parenteral formulations
JPH06321771A (ja) 経皮投与用基剤
US5183665A (en) Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
JPH0755911B2 (ja) 経皮吸収促進剤及びこれを含有する皮膚外用製剤
JPS62187415A (ja) 経皮吸収促進用組成物
JPH083073A (ja) 経皮吸収促進剤及び皮膚外用剤
JPS6287528A (ja) Ｎ−アルキルモルホリン含有外皮投与用組成物
Shaaya Transdermal dosage forms of papaverine
JPH08143474A (ja) 経皮吸収促進剤
KR20010029743A (ko) 국소 마취용 약용팩 조성물
JPH083071A (ja) 経皮吸収促進剤及び皮膚外用剤

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed